ŠALTINIAI

1. International Federation of Psoriasis Associations. Brochure-Psoriasis-is-a-serious-disease-deserving-global-attention. https://ifpa-pso.com/wp-content/uploads/2017/01/Brochure-Psoriasis-is-a-serious-disease-deserving-global-attention.pdf. Prieiga 2020 m. gruodžio 21 d.

2. Global Report on Psoriasis. World Health Organization 2016. http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf. Prieiga 2020 m. gruodžio 21 d.

3. Queiro R. et al. Rheumatology 2014;53:1178-1185. doi:10.1093/rheumatology/ket363.  

4. Causes and triggers. National Psoriasis Foundation. https://www.psoriasis.org/about-psoriasis/causes. Prieiga 2020 m. gruodžio 21 d.

5. Mrowietz U. et al.  Arch Dermatol Res (2011) 303:1–10.

6. Warren R. et al.  British Journal of Dermatology (2020). 

7. National Psoriasis Foundation. Psoriasis Statistics. https://www.psoriasis.org/psoriasis-statistics. Prieiga 2020 m. gruodžio 21 d.

8. https://hi.lt/news/1539/1203/Spalio-29-oji-Pasauline-zvynelines-diena.html. Prieiga 2020 m. gruodžio 21 d.

9. Higienos Institutas. https://stat.hi.lt/default.aspx?report_id=168.

Prieiga 2020 m. gruodžio 21 d.

10. Reddy V. et al. Journal of Inflammation Research 2020:13 53–60.

11. J F. Amatore JF. et al. EADV 2019, 33, 464–483.

12. https://e-seimas.lrs.lt/portal/legalAct/lt/TAD/da004c41c75d11eab2168935922ac3ab. Prieiga 2020 m. gruodžio 21 d.

13. British Association of Dermatologists. Topical treatments for psoriasis. August 2017.

http://www.bad.org.uk/shared/get-file.ashx?id=123&itemtype=document. Prieiga 2020 m. gruodžio 21 d.

14. British Association of Dermatologists. Phototherapy. July 2018.

http://www.bad.org.uk/shared/get-file.ashx?id=175&itemtype=document. Prieiga 2020 m. gruodžio 21 d.

15. Czarnecka-Operacz M, Sadowska-Przytocka A. Postep Derm Alergol 2014; XXXI, 6: 392–400. DOI: 10.5114/pdia.2014.47121

16. http://www.vlk.lt/veikla/veiklos-sritys/kompensuojamieji-vaistai/aktualijos/Documents/1030%20Pa%c5%beyma%20Q4%202020bLMV.pdf. Prieiga 2020 m. gruodžio 21 d.

17. Egeberg A.et all. JEADV 2020, 34, 39–46.

18. Brocker c. et al. Hum Genomics. 2010; 5(1): 30.–55.

19. Hawkes JE, et al. J Allergy Clin Immunol 2017;140:645–653.

20. British Association of Dermatologists. Treatments for moderate to severe psoriasis. January 2017. http://www.bad.org.uk/shared/get-file.ashx?id=124&itemtype=document. Prieiga 2020 m. gruodžio 21 d.

21. Girolomoni G, et al. JEADV.2017;31:1616-26. 

22.Gordon K, et al. Lancet 2018;392:650–661. 

23. Reich K, et al. Lancet 2019;394:576–86. 

24. Lluís Puig (2017) The role of IL 23 in the treatment of psoriasis, Expert Review of Clinical Immunology, 13:6, 525-534. 

25. Yeung H. et al. JAMA Dermatol. 2013 October 1; 149(10): 1173–1179. 

26. https://e-seimas.lrs.lt/portal/legalAct/lt/TAD/TAIS.94805/asr. Prieiga 2020 m. gruodžio 21 d.

27. Kerdel F. et al.  J Drugs Dermatol. 2018; 17(7):737-74222. NICE guidelines. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making. Prieiga 2020 m. gruodžio 21 d.

28. Hawkes JE, et al. J Allergy Clin Immunol. 2017;140(3):645-653.

29. Kim J, Krueger JG. Dermatol Clin. 2015;33(1):13-23.

30. Gaffen SL, et al. Nat Rev Immunol. 2014;14(9):585-600.

31. Cai Y, et al. Cell Mol Immunol. 2012;9(4):302-309.

32. British Association of Dermatologists. Treatments for moderate to severe psoriasis. January 2017.  http://www.bad.org.uk/shared/get-file.ashx?id=124&itemtype=document. Prieiga 2020 m. gruodžio 21 d.

33. Rich SJ, Bello-Quintero CE. J Manag Care Pharm. 2004 Jul-Aug;10(4):318-25. 

34. Pathirana, D., et al. JEADV. October 2009. 23(2)5-70. DOI: 10.1111/j.1468-3083.2009.03389. 

35. Menter A, et al. JAAD. April 2019. 80(4): 1029–1072. 

36. Gisondi P, et al. JEADV. May 2017. 34(5):774–790. 

37. National Institute for Health and Care Excellence. Psoriasis: assessment and management. September 2017. https://www.nice.org.uk/guidance/cg153. Prieiga 2020 m. gruodžio 21 d.

APIE LIGĄ

VIDUTINĖ / SUNKI
PSORIAZĖ

GYDYMAS

KUR KREIPTIS?

TIESA AR

MITAS?

PROJEKTO INICIATORIUS

Asociacija „Odos akademija“

PROJEKTO PARTNERIS

UDA-25199-EEMEA